Recommended use: A D3 and MK-7 combination has a synergistic benefit compared to single nutrient therapy. Vitamin D and vitamin K have diverse and complementary physiological functions, close associations with age-related and chronic diseases, and a strong body of clinical evidence documenting widespread insufficiency and therapeutic potential. Vitamins K and D have complementary physiological functions, and clinical trials have shown synergistic benefit for both osteoporosis and cardiovascular disease when used together.
Vitamin K2 (Menaquinone) (MK-7) (Natto Bean) 120 mcg
Vitamin D3 (Cholecalciferol) 1000 IU (25 mcg)
Non-medicinal ingredients: Medium chain triglycerides, softgel (gelatin, glycerin, purified water, caramel, titanium dioxide), yellow beeswax, non-GMO sunflower lecithin.
Recommended dose: 1 softgel per day or as directed by a health care practitioner.
Amount: 60 softgels
Caution: Consult a health care practitioner prior to use if you are taking blood thinners. Keep out of reach of children. When taken with a thiazide medication (diuretic), vitamin D may increase the risk for hypercalcemia. Also, vitamin D may improve insulin sensitivity and lower blood pressure, requiring a reduction in dosage of hypertension and/or diabetic medications. Vitamin K may antagonize the effect of some anticoagulant medications, particularly warfarin, and should be taken together only with medical supervision. Recent data suggests vitamin K supplementation may stabilize INRs and reduce adverse effects among those on vitamin K antagonists, but combined use should be carefully monitored.